Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis.

Cory TJ, Birket SE, Murphy BS, Hayes D Jr, Anstead MI, Kanga JF, Kuhn RJ, Bush HM, Feola DJ.

J Cyst Fibros. 2014 Mar;13(2):164-71. doi: 10.1016/j.jcf.2013.08.007. Epub 2013 Sep 7.

2.

Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Konstan MW, Liou TG, Strausbaugh SD, Ahrens R, Kanga JF, Graff GR, Moffett K, Millard SL, Nasr SZ, Siméon E, Spénard J, Grondin J.

Gastroenterol Res Pract. 2010;2010:898193. doi: 10.1155/2010/898193. Epub 2010 Dec 8.

3.

Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.

Rosenfeld M, Emerson J, McNamara S, Joubran K, Retsch-Bogart G, Graff GR, Gutierrez HH, Kanga JF, Lahiri T, Noyes B, Ramsey B, Ren CL, Schechter M, Morgan W, Gibson RL; EPIC Study Group Participating Clinical Sites.

Pediatr Pulmonol. 2010 Sep;45(9):934-44. doi: 10.1002/ppul.21279.

PMID:
20597081
4.

Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure.

Hayes D Jr, Kanga JF, Anstead MI, Kuhn RJ.

Pediatr Pulmonol. 2008 May;43(5):511-3. doi: 10.1002/ppul.20791.

PMID:
18383117

Supplemental Content

Loading ...
Support Center